Latest News

STAT Plus: Lawmakers ask FTC to scrutinize pharma mergers over antitrust concerns

Worried about a lack of competition and rising drug prices, several U.S. senators have asked the Federal Trade Commission to scrutinize pharmaceutical mergers and singled out a pair of pending deals — AbbVie’s proposed acquisition of Allergan, and Bristol-Myers Squibb’s bid to buy Celgene.

In arguing for greater scrutiny, the lawmakers noted there has been a “steady increase” in mergers and acquisitions in the pharmaceutical industry and also pointed to multibillion-dollar deals announced earlier this year by Pfizer and Roche.

Continue to STAT Plus to read the full story…

Source link

Related posts

Blood-based biomarkers for Alzheimer's disease – an update


Watermelon, Starchy Veggies Good For Gut Health: What You Need To Know


Evidation Health CEO: For better clinical outcomes, look to patients' data, devices


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy